| Home | E-Submission | Sitemap | Editorial Office |  
top_img
    
REVIEW ARTICLE 2022 February 18
Challenges in the Use of Targeted Therapies in Non–Small Cell Lung Cancer
Precision oncology has fundamentally changed how we diagnose and treat cancer. In recent years, there has been a significant change in the management of patients with oncogene-addicted advanced-stage NSCLC. Increasing amounts of identifiable oncogene drivers have led to the deve...
SPECIAL ARTICLE 2022 March 16
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019
Purpose The current study provides national cancer statistics and their secular trends in Korea, including incidence, mortality, survival, and prevalence in 2019. Materials and Methods Incidence, survival, and prevalence rates of cancer were calculated using the Korea Nationa...
SPECIAL ARTICLE 2022 March 21
Prediction of Cancer Incidence and Mortality in Korea, 2022
Purpose This study aimed to report the projected cancer incidence and mortality for the year 2022 to estimate Korea’s current cancer burden. Materials and Methods Cancer incidence data from 1999 to 2019 were obtained from the Korea National Cancer Incidence Database, and ca...
ORIGINAL ARTICLE 2021 August 2
Validation of Cancer Diagnosis Based on the National Health Insurance Service Database versus the National Cancer Registry Database in Korea
Purpose This study aimed to assess the feasibility of operational definitions of cancer patients in conducting cancer-related studies using the claims data from the National Health Insurance Service (NHIS). Materials and Methods Cancer incidence data were obtained from the K...
Current Issue
Volume 54(2); Apr 2022
Volume 54(1); January 2022
Volume 53(4); October 2021
RSS feed


(2018~2022)

  • Most-cited are based on citations from 2020 ~ 2022.
  • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017
    Seri Hong, Young-Joo Won, Young Ran Park, Kyu-Won Jung, Hyun-Joo Kong, Eun Sook Lee, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2020;52(2):335-350.   Published online March 16, 2020    DOI: https://doi.org/10.4143/crt.2020.206
                                     Cited By 196
    Prediction of Cancer Incidence and Mortality in Korea, 2020
    Kyu-Won Jung, Young-Joo Won, Seri Hong, Hyun-Joo Kong, Eun Sook Lee
    Cancer Res Treat. 2020;52(2):351-358.   Published online March 16, 2020    DOI: https://doi.org/10.4143/crt.2020.203
                                     Cited By 66
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018
    Seri Hong, Young-Joo Won, Jae Jun Lee, Kyu-Won Jung, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2021;53(2):301-315.   Published online March 17, 2021    DOI: https://doi.org/10.4143/crt.2021.291
                                  Supplementary         Cited By 64
    Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer
    Ji Eun Oh, Min Ju Kim, Joohyung Lee, Bo Yun Hur, Bun Kim, Dae Yong Kim, Ji Yeon Baek, Hee Jin Chang, Sung Chan Park, Jae Hwan Oh, Sun Ah Cho, Dae Kyung Sohn
    Cancer Res Treat. 2020;52(1):51-59.   Published online May 7, 2019    DOI: https://doi.org/10.4143/crt.2019.050
                                  Supplementary         Cited By 35
    PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs
    Yujun Park, Jiwon Koh, Hee Young Na, Yoonjin Kwak, Keun-Wook Lee, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee
    Cancer Res Treat. 2020;52(3):661-670.   Published online January 10, 2020    DOI: https://doi.org/10.4143/crt.2019.718
                                  Supplementary         Cited By 25
    Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response
    Junho Kang, Jae Ho Jeong, Hee-Sang Hwang, Sang Soo Lee, Do Hyun Park, Dong Wook Oh, Tae Jun Song, Ki-Hun Kim, Shin Hwang, Dae Wook Hwang, Song Cheol Kim, Jin-hong Park, Seung-Mo Hong, Kyu-pyo Kim, Baek-Yeol Ryoo, Changhoon Yoo
    Cancer Res Treat. 2020;52(2):594-603.   Published online December 18, 2019    DOI: https://doi.org/10.4143/crt.2019.493
                                     Cited By 23
    Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving
    De-Ying Wang, Na Li, Yu-Lan Cui
    Cancer Res Treat. 2020;52(3):798-814.   Published online March 3, 2020    DOI: https://doi.org/10.4143/crt.2019.498
                                  Supplementary         Cited By 21
    Cathepsin C Interacts with TNF-α/p38 MAPK Signaling Pathway to Promote Proliferation and Metastasis in Hepatocellular Carcinoma
    Guo-Pei Zhang, Xiao Yue, Shao-Qiang Li
    Cancer Res Treat. 2020;52(1):10-23.   Published online April 26, 2019    DOI: https://doi.org/10.4143/crt.2019.145
                                     Cited By 18
    Gastrointestinal cancer
    A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair–Deficient/Microsatellite Instability–High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer
    Jwa Hoon Kim, Sun Young Kim, Ji Yeon Baek, Yong Jun Cha, Joong Bae Ahn, Han Sang Kim, Keun-Wook Lee, Ji-Won Kim, Tae-You Kim, Won Jin Chang, Joon Oh Park, Jihun Kim, Jeong Eun Kim, Yong Sang Hong, Yeul Hong Kim, Tae Won Kim
    Cancer Res Treat. 2020;52(4):1135-1144.   Published online April 24, 2020    DOI: https://doi.org/10.4143/crt.2020.218
                                  Supplementary         Cited By 17
    Prediction of Cancer Incidence and Mortality in Korea, 2021
    Kyu-Won Jung, Young-Joo Won, Seri Hong, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
    Cancer Res Treat. 2021;53(2):316-322.   Published online March 17, 2021    DOI: https://doi.org/10.4143/crt.2021.290
                                     Cited By 16
    Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer
    Mei Hua Jin, Ah-Rong Nam, Ji Eun Park, Ju-Hee Bang, Yung-Jue Bang, Do-Youn Oh
    Cancer Res Treat. 2020;52(1):149-166.   Published online June 25, 2019    DOI: https://doi.org/10.4143/crt.2019.183
                                  Supplementary         Cited By 15
    Association of Body Composition with Long-Term Survival in Non-metastatic Rectal Cancer Patients
    Jin Soo Han, Hyoseon Ryu, In Ja Park, Kyung Won Kim, Yongbin Shin, Sun Ok Kim, Seok-Byung Lim, Chan Wook Kim, Yong Sik Yoon, Jong Lyul Lee, Chang Sik Yu, Jin Cheon Kim
    Cancer Res Treat. 2020;52(2):563-572.   Published online December 3, 2019    DOI: https://doi.org/10.4143/crt.2019.249
                                     Cited By 14
    Fibroblast Growth Factor Receptor 1 (FGFR1) Amplification Detected by Droplet Digital Polymerase Chain Reaction (ddPCR) Is a Prognostic Factor in Colorectal Cancers
    Jeong Mo Bae, Xianyu Wen, Tae-Shin Kim, Yoonjin Kwak, Nam-Yun Cho, Hye Seung Lee, Gyeong Hoon Kang
    Cancer Res Treat. 2020;52(1):74-84.   Published online May 8, 2019    DOI: https://doi.org/10.4143/crt.2019.062
                                  Supplementary         Cited By 13
    Validation of the 8th Edition of the American Joint Committee on Cancer Staging System for Gallbladder Cancer and Implications for the Follow-up of Patients without Node Dissection
    You-Na Sung, Minjeong Song, Jae Hoon Lee, Ki Byung Song, Dae Wook Hwang, Chul-Soo Ahn, Shin Hwang, Seung-Mo Hong
    Cancer Res Treat. 2020;52(2):455-468.   Published online October 17, 2019    DOI: https://doi.org/10.4143/crt.2019.271
                                     Cited By 13
    Computed Tomography–Determined Sarcopenia Is a Useful Imaging Biomarker for Predicting Postoperative Outcomes in Elderly Colorectal Cancer Patients
    Hailun Xie, Yizhen Gong, Jiaan Kuang, Ling Yan, Guotian Ruan, Shuangyi Tang, Feng Gao, Jialiang Gan
    Cancer Res Treat. 2020;52(3):957-972.   Published online April 17, 2020    DOI: https://doi.org/10.4143/crt.2019.695
                                     Cited By 13
    Head/neck cancer
    Nomogram for Predicting Central Lymph Node Metastasis in Papillary Thyroid Cancer: A Retrospective Cohort Study of Two Clinical Centers
    Zheyu Yang, Yu Heng, Jianwei Lin, Chenghao Lu, Dingye Yu, Lei Tao, Wei Cai
    Cancer Res Treat. 2020;52(4):1010-1018.   Published online June 9, 2020    DOI: https://doi.org/10.4143/crt.2020.254
                                     Cited By 13
    Disparities in the Participation Rate of Colorectal Cancer Screening by Fecal Occult Blood Test among People with Disabilities: A National Database Study in South Korea
    Dong Wook Shin, Dongkyung Chang, Jin Hyung Jung, Kyungdo Han, So Young Kim, Kui Son Choi, Won Chul Lee, Jong Heon Park, Jong Hyock Park
    Cancer Res Treat. 2020;52(1):60-73.   Published online May 7, 2019    DOI: https://doi.org/10.4143/crt.2018.660
                                  Supplementary         Cited By 12
    Implication of the Life-Sustaining Treatment Decisions Act on End-of-Life Care for Korean Terminal Patients
    Jung Sun Kim, Shin Hye Yoo, Wonho Choi, Yejin Kim, Jinui Hong, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo
    Cancer Res Treat. 2020;52(3):917-924.   Published online March 23, 2020    DOI: https://doi.org/10.4143/crt.2019.740
                                     Cited By 12
    General
    Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004–2018
    Seri Hong, Yun Yeong Lee, Jaeho Lee, Yeol Kim, Kui Son Choi, Jae Kwan Jun, Mina Suh
    Cancer Res Treat. 2021;53(2):330-338.   Published online October 20, 2020    DOI: https://doi.org/10.4143/crt.2020.263
                                  Supplementary         Cited By 12
    Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30–Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial
    Seok Jin Kim, Dok Hyun Yoon, Jin Seok Kim, Hye Jin Kang, Hye Won Lee, Hyeon-Seok Eom, Jung Yong Hong, Junhun Cho, Young Hyeh Ko, Jooryung Huh, Woo-Ick Yang, Weon Seo Park, Seung-Sook Lee, Cheolwon Suh, Won Seog Kim
    Cancer Res Treat. 2020;52(2):374-387.   Published online August 13, 2019    DOI: https://doi.org/10.4143/crt.2019.198
                                     Cited By 11
    Korean Cancer Association
    E-Submission
    EndNote Output Style
    Email Alert
    Impact factor
    SCImago Journal & Country Rank
    PubMed Central
    MEDLINE/PubMed
    Scopus
    KoreaMed
    KoMCI
    ScienceCentral
    GoogleScholar
    Similarity Check
    Crossref Cited-by Linking
    CrossMark
    Funder Registry
    Metadata
    ORCID
    COPE
    Editorial Office
    Korean Cancer Association
    Room 1824, Gwanghwamun Officia
    92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
    TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
    About |  Browse Articles |  Current Issue |  For Authors and Reviewers
    Copyright © Korean Cancer Association.                 Developed in M2PI